ProtoKinetix Inc (PKTX)

[Past and present]

PKTX'S COMMERCIAL APPLICATIONS >> STEM CELLS AND AAGP™

Stem cells are one of the most promising areas of R&D in biotechnology today. Medical Scientists believe that stem cells offer the potential to cure or mitigate a host of pervasive and debilitating diseases and conditions such as multiple sclerosis, Parkinson’s Alzheimer’s, and diabetes. They also believe that stem cells can be used to repair damaged tissues or cells caused by caused by injuries to organs, limbs, and the spinal cord.

Stem cells are usually small in number, expensive to collect and have a delicate constitution. They are meant to live inside the body, however medical research and development requires them to live and function outside the body. This environment, along with the processes of collection, purification, separation, expansion, cryopreservation and thaw are all stresses that tend to cause stem cells to die or become dysfunctional in some way. Therefore the inventory of healthy stem cells is of significant importance and presents challenges for researchers and clinicians.

AAGP™ has demonstrated an ability to increase the inventory of viable stem cells. In laboratory controlled tests AAGP™ treated cells have survived harsh environmental stresses such as cryopreservation hydrogen peroxide oxidation, inflammation from interleukin 1Beta, UV-C radiation, and nutrient deprivation.